Analysts at Morgan Stanley raised the price target of Alexion Pharmaceuticals (NASDAQ: ALXN) to $121.00 on Tuesday. This is up from the earlier $120.00....
DJIA, SPX and Nasdaq advanced on a weekly basis
Hopes related to a US stimulus package boosted the market’s sentiment
The US President Trump proposed a...
A well-known digital asset firm, Diginex, recently went through a reverse merger with 8i Enterprises.
The move allowed it to go public and get listed...
DJIA and S&P 500 had their fourth straight weekly declines
The Nasdaq Index advanced on a weekly basis after falling the previous three
US Congress will...